Dr. Tyler Crosby, MD

Dr. Crosby practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Crosby's NPI, 1114314952, was assigned on April 20, 2015. Dr. Crosby graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2015. Dr. Crosby holds New York license 309513.

Dr. Crosby's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Crosby's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Crosby is also affiliated with Tisch Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Crosby to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crosby practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Crosby's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Crosby is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Crosby's licenses on file in 3 states: New York, Louisiana and California.

Dmand AI lists larynx and vocal cord disease, swimmer's ear and tinnitus among the conditions Dr. Crosby treats.

CMS data shows 360 Medicare services from Dr. Crosby across 7 procedure codes in 2024, for 201 Medicare patients. Medicare paid $34,865 for them. Every service was in an office.

CMS counts 201 Medicare patients who saw Dr. Crosby in 2024. The largest group is 65 to 74, with 94 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 30% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Crosby's median patient age at 68, with 49% women.

In 2024, Dr. Crosby wrote 92 Medicare Part D claims for 38 patients. 98% of them were for generic drugs. CMS names the drug for 43 of them, across 2 drugs with 11 or more claims each, at $930 in total drug cost. In 2022, CMS named 20 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Crosby for performance year 2024, reported as part of a group. Dr. Crosby accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Crosby as offering telehealth.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Crosby, published from 2016 to 2025. 2025 was the busiest year, with 4. The most frequent topics are Laryngostenosis, Constriction, Pathologic and Hydrodynamics. Dr. Crosby has published most often in Laryngoscope. Dr. Crosby's most frequent co-authors are Milan Amin, MD, Paul Edward Kwak, MD and Lacey Katherine Adkins, MD.

CMS Open Payments shows 7 general payments to Dr. Crosby from 5 drug and device companies from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Acclarent, Inc paid the most, $126.

Dr. Crosby graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2015.

Dr. Crosby is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.